The European Commission granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Bracco-EU-Autho

More Like This

PR Newswire associated0

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion

PR Newswire associated0

Guerbet announces marketing authorisation approval of Elucirem™ (Gadopiclenol) in the European Union

A radiologist looking at MRI exam images (Photo: Business Wire)

GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

Business Wire logo

Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines

PR Newswire associated0

BRACCO TRIPLES PRODUCTION OF ITS INNOVATIVE CONTRAST AGENT FOR ULTRASOUND IN GENEVA, INAUGURATING A SECOND FACILITY

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

PR Newswire associated0

Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome

PR Newswire associated0

Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ (vibegron) in overactive bladder.